pathogenic gene
Showing 1 - 25 of 6,751
Arrhythmogenic Cardiomyopathy, PKP2-ACM, PKP2-ARVC Trial (LX2020)
Not yet recruiting
- Arrhythmogenic Cardiomyopathy
- +2 more
- LX2020
- (no location specified)
Oct 25, 2023
Universal- Versus Guidelines-Directed Genetic Testing for
Recruiting
- Genetic Predisposition
-
Amman, JordanKing Hussein Cancer Center
Aug 17, 2022
Follow-up Study on Female Carriers With DMD Gene Variants
Not yet recruiting
- Muscular Dystrophy
- +2 more
- No intervention
-
Copenhagen, DenmarkCopenhagen neuromuscular center
Feb 7, 2023
Patients With G2019S LRRK2 Parkinson's Disease
Suspended
- Patients With Parkinson's Disease (PD) Caused by the p.Gly2019Ser (G2019S) Pathogenic Mutation of the Leucine-Rich Repeat Kinase 2 (LRRK2) Gene
- Observational
-
Culver City, CaliforniaScience 37
Aug 15, 2022
Prognosis Study of Renal Transplantation in Children
Completed
- Kidney Failure
- molecular diagnosis
-
Shanghai, Shanghai, ChinaChildren's hospital of Fudan university
Jan 4, 2022
Cancer, Cancer Metastatic, BRAF V600E Trial in Indianapolis (Abemaciclib, LY3214996)
Recruiting
- Cancer
- +6 more
-
Indianapolis, IndianaIndiana University Hospital / IU Simon Cancer Center
Jan 12, 2023
Pathogenic Germline Gene Variants of Colorectal Polyposis in
Recruiting
- Colorectal Polyposis
- germline variants
-
Beijing, Beijing, China
- +4 more
Jul 14, 2021
Genital Diseases, Female Trial in Paris, Toulouse (Pelvic ultrasound, blood sample)
Not yet recruiting
- Genital Diseases, Female
- Pelvic ultrasound
- blood sample
-
Paris, France
- +2 more
Feb 4, 2021
X-Linked Retinitis Pigmentosa Trial (rAAV2tYF-GRK1-hRPGRco)
Not yet recruiting
- X-Linked Retinitis Pigmentosa
- rAAV2tYF-GRK1-hRPGRco
- (no location specified)
May 19, 2021
X-Linked Retinitis Pigmentosa Trial in United States (rAAV2tYF-GRK1-RPGR)
Recruiting
- X-Linked Retinitis Pigmentosa
- rAAV2tYF-GRK1-RPGR
-
Jacksonville, Florida
- +6 more
Jul 13, 2021
Parkinson's Disease Trial in Worldwide (BIA 28-6156 10 mg, BIA 28-6156 60 mg, Placebo)
Recruiting
- Parkinson's Disease
- BIA 28-6156 10 mg
- +2 more
-
Los Angeles, California
- +73 more
Apr 18, 2023
Aniridia Trial (Tear collection)
Not yet recruiting
- Aniridia
- Tear collection
- (no location specified)
Sep 29, 2022
MRI-phenotyping of Patients With Pathogenic Anoctamin 5 Variants
Recruiting
- Limb Girdle Muscular Dystrophy
- No intervention
-
Copenhagen, DenmarkNanna Scharff Poulsen
Jan 17, 2023
Gene Mutation Spectrum of Malignant Hyperthermia in China
Recruiting
- Malignant Hyperthermia
- gene sequencing
-
Chengdu, Sichuan, ChinaWest China Hospital, Sichuan University
Nov 9, 2021
Cancer in Inherited Bone Marrow Failure Syndromes
Recruiting
- Diamond Blackfan Anemia
- +4 more
-
Bethesda, Maryland
- +1 more
Jan 24, 2023
Inherited Cancer Syndrome, Prostate Cancer, Colorectal Cancer Trial in Nashville (Correlative Studies (Survey), Correlative
Not yet recruiting
- Inherited Cancer Syndrome
- +4 more
- Correlative Studies (Survey)
- +4 more
-
Nashville, TennesseeVanderbilt-Ingram Cancer Center
Jul 5, 2022
Mitochondrial Dysfunctions Driving Insulin Resistance
Recruiting
- Mitochondrial Myopathies
- +2 more
-
Copenhagen, DenmarkRigshospitalet
Oct 16, 2023
Amyloidosis, Hereditary Trial in Richmond (Registry)
Not yet recruiting
- Amyloidosis, Hereditary
- Registry
-
Richmond, VirginiaVirginia Commonwealth University
Jul 25, 2023
Decoding the Genetic Landscape of Skeletal Diseases
Recruiting
- Genetic Skeletal Diseases
- +3 more
-
Stockholm, SwedenKarolinska University Hospital
May 16, 2023
Pigmentary; Dermatosis Trial (Blood sample, Cutaneous biopsy, High troughput sequencing of human's exome)
Not yet recruiting
- Pigmentary; Dermatosis
- Blood sample
- +2 more
- (no location specified)
Oct 3, 2023
Protection Response to Cellular Stress in BPAN's Patient Study
Not yet recruiting
- Children and Adults With BPAN Carrying Pathogenic Variants of WDR45
- BPAN Patients
-
Bron, FranceService de génétique - Laboratoire de Biologie Médicale Multi-Si
Jul 13, 2023
Her-2 Negative Breast Cancer, HRR Gene Mutation Trial in Guangzhou (Camrelizumab, Fluzoparib, Nab-paclitaxel)
Recruiting
- Her-2 Negative Breast Cancer
- HRR Gene Mutation
- Camrelizumab
- +2 more
-
Guangzhou, Guangdong, ChinaFirst Affiliated Hospital, Sun Yat-Sen University
Mar 7, 2023
3 Year Follow up on ANO5 Patients
Active, not recruiting
- Neuromuscular Diseases
- Limb Girdle Muscular Dystrophy
- No intervention - pure observational study
-
Copenhagen, Region Hovedstaden, DenmarkCopenhagen Neuromuscular Center
Jan 25, 2022